Clinical Trial Update: Extended Access of Momelotinib in Adults With Myelofibrosis [Phase 2]

View source ↗

Summary

This clinical trial update notes extended-access use of momelotinib in adults with myelofibrosis, including primary myelofibrosis and related post-ET and post-P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Post-essential Thrombocythemia Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Drugs mentioned

• Momelotinib (momelotinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF) | Phase 2 | Status: ACTIVE_NOT_RECRUITING